Drug Shortage Report for ALLERJECT
Report ID | 4027 |
Drug Identification Number | 02382059 |
Brand name | ALLERJECT |
Common or Proper name | EPINEPHRINE SOLUTION FOR INJECTION, USP |
Company Name | VALEO PHARMA INC |
Market Status | MARKETED |
Active Ingredient(s) | EPINEPHRINE |
Strength(s) | 0.15MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAMUSCULAR |
Packaging size | 1 UNITS/1 CARTON |
ATC code | C01CA |
ATC description | CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2017-03-23 |
Actual start date | 2017-03-23 |
Estimated end date | 2020-05-19 |
Actual end date | 2020-05-19 |
Shortage status | Resolved |
Updated date | 2020-05-29 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 16667 HYMUS BLVD. KIRKLAND, QUEBEC CANADA H9H 4R9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2020-05-29 | French | Compare |
v4 | 2020-05-29 | English | Compare |
v3 | 2017-03-24 | English | Compare |
v2 | 2017-03-23 | French | Compare |
v1 | 2017-03-23 | English | Compare |
Showing 1 to 5 of 5